Powered by

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Regulus Therapeutics Inc. (RGLS)

Feb 3, 2017 - Legal Monitor Worldwide

(GlobeNewswire) - Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Regulus Therapeutics Inc. (Regulus or the Company) (NASDAQ:RGLS) in the United States District Court for the Southern District of California on behalf of persons or entities who purchased or otherwise acquired Regulus stock between January 21, 2016 and June 27, 2016, inclusive (the Class Period), seeking to recover compensable damages caused by defendants violations of the Securities Exchange

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox